CClinicalTrials.gg
Sign In
Status unknownNCT01781897Updated Mar 19, 2015

Electroacupuncture for the Treatment of Functional Constipation

A Phase 1 interventional study of acupuncture and mosapride in Functional Constipation, sponsored by Huazhong University of Science and Technology. Status unknown at 3 sites in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2015-03-19.

Sponsored by Huazhong University of Science and Technology · Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
243
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the effect of electroacupuncture on functional constipation.

Read the detailed description

This study will supply significant evidence for using acupuncture to treat functional constipation(FC), and will help us to identify whether it is a therapeutic effect rather than a placebo effect.

02

Conditions studied

  • Functional Constipation

Browse trials for

Keywords

  • acupuncture
  • electro-acupuncture
03

In context

Constipation

1,018 studies on the registry are indexed under Constipation; 139 are open to participants now.

This study's planned enrollment of 243 is above the median of 80 across 850 interventional studies indexed under Constipation.

Browse Constipation studies →

Lead sponsor

Huazhong University of Science and Technology is the lead sponsor of 241 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • functional constipation according to the Roman Ⅲ standard;
  • aged between 18 and 65 years old

Exclusion criteria

Exclusion criteria:

  • unconsciousness, psychosis or can't express subjective symptoms;
  • pregnant women or women in lactation period;
  • serious diseases of the heart, liver, kidney, and others;
  • bleeding disorders.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
243 participants (estimated)

Study arms

  • Active comparator
    mosapride

    mosapride

    Drug: mosapride

  • Experimental
    Electro-acupuncture

    Electro-acupuncture

    Device: acupuncture

  • Sham comparator
    mosapride + sham acupuncture

    mosapride + sham acupuncture

    Device: acupuncture · Drug: mosapride

Interventions

  • Deviceacupuncture

    sterile, disposable needles with a length of 40 mm and a diameter of 0.25 mm (Dongbang® Acupuncture Inc, Korea)

    Also known as: Park true/sham devices

  • Drugmosapride

    Mosapride Citrate tablet（5mg），Dainippon Sumitomo pharmaceutical Co.Ltd,Japan

    Also known as: GASMOTIN

06

What researchers measure

Primary outcomes

  1. number of defecation per week

    Time frame: 3 years

07

Study locations

3 of 3 sites recruiting
  • Hospital of Huazhong University of Science and Technology
    Wuhan, Hubei 430000, China
    • Jing Gui, Master · Contact · 841946472@qq.com · +8615327285070
    • Jing Gui, Master · Principal investigator
    Recruiting
  • Hubei Provincial Hospital of TCM
    Wuhan, Hubei 430000, China
    • Feng Hu, Doctor · Contact · 351552735@qq.com · +8613469974981
    • Feng Hu, Doctor · Principal investigator
    Recruiting
  • Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei 430030, China
    • Guangying Huang, doctor · Contact · Gyhuang@tjh.tjmu.edu.cn · 86-027-8366-3266
    • Mingmin Zhang, Doctor · Principal investigator
    • Cuihong Zheng, Doctor · Principal investigator
    • Xiaohu Xu, Doctor · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01781897
Lead sponsor
Huazhong University of Science and Technology
Responsible party
Guangying Huang (professor, Huazhong University of Science and Technology) — Principal investigator
First posted
Feb 1, 2013
Start date
Feb 2013
Primary completion
Dec 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Mar 19, 2015

Study contacts

Guangying Huang, Doctor
Contact
Gyhuang@tjh.tjmu.edu.cn
86-027-8366-3266
Xiaohu Xu, Doctor
principal investigator · HUST(Huazhong University of Science and Technology) Hospital
Feng Hu, Master
principal investigator · Hubei Hospital of Traditional Chinese Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Constipation→

Other studies from this sponsor

Huazhong University of Science and Technology

Start the discussion